# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 61: Amendment to regulation 78B

Extent: E+W+S+N.I.

In regulation 78B (post authorisation requirements in relation to UKMA(GB) for advanced therapy medicinal products)—
(a) in the heading, for “UKMA(GB)” substitute “UKMA(UK)(Category 1)”;
(b) in paragraph (1)—
(i) in the opening words, for “UKMA(GB)” substitute “UKMA(UK)(Category 1)”;
(ii) in sub-paragraph (c), for “UKMA(GB)” substitute “UKMA(UK)(Category 1)”;
(iii) in sub-paragraph (d), for “UKMA(GB)” substitute “UKMA(UK)(Category 1)”;
(c) in both places in paragraph (2), for “UKMA(GB)” substitute “UKMA(UK)(Category 1)”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/61 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-61
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.